Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Gait Posture. 2021 May 27;88:161–166. doi: 10.1016/j.gaitpost.2021.05.022

Table 5.

Multivariate regression model to predict FES-I scores from a model composed of age, sex, BMI, VPT, time since cancer diagnosis and gait speed (Model 1), and another model composed of age, sex, BMI, VPT, time since cancer diagnosis and stride length (Model 2).

Independent variables β P-value 95% CI VIF
Model 1
Age −0.014 0.929 −0.727, 0.666 1.195
Sex 0.219 0.163 −2.150, 12,126 1.099
BMI 0.249 0.119 −0.193, 1.601 1.133
Peripheral neuropathy severity (VPT) 0.080 0.616 −0.505, 0.836 1.191
Time since cancer diagnosis 0.105 0.523 −0.202, 0.388 1.244
Gait speed −0.517 0.004 −47.693, −10.281 1.250
Model 2
Age 0.009 0.956 −0.700, 0.739 1.184
Sex 0.169 0.315 −3.882, 11.595 1.200
BMI 0.219 0.186 −0.318, 1.555 1.148
Peripheral neuropathy severity (VPT) 0.130 0.444 −0.190, 0.421 1.235
Time since cancer diagnosis 0.215 0.179 −0.216, 1.100 1.065
Stride length −0.453 0.011 −46.168, −6.690 1.192

Note: P-values correspond to the standardized coefficients (β).

Abbreviations: FES-I = Falls-Efficacy Scale-International; VIF = variance inflation factor; BMI = body mass index; VPT = vibration perception threshold; CI = confidence interval.